These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9709291)

  • 1. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
    Chang HR; Cole B; Bland KI
    J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of mammography to reveal nonpalpable breast cancer in women with palpable breast masses.
    Rosen EL; Sickles E; Keating D
    AJR Am J Roentgenol; 1999 Feb; 172(2):309-12. PubMed ID: 9930773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a multidisciplinary breast center. Analysis of disease discovered.
    Silverstein MJ; Gamagami P; Masetti R; Legmann MD; Craig PH; Gierson ED
    Surg Oncol Clin N Am; 1997 Apr; 6(2):301-14. PubMed ID: 9115497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic mammography and ultrasonography for palpable and nonpalpable breast cancer in women aged 30 to 39 years.
    Osako T; Iwase T; Takahashi K; Iijima K; Miyagi Y; Nishimura S; Tada K; Makita M; Akiyama F; Sakamoto G; Kasumi F
    Breast Cancer; 2007; 14(3):255-9. PubMed ID: 17690501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palpable presentation of breast cancer persists in the era of screening mammography.
    Mathis KL; Hoskin TL; Boughey JC; Crownhart BS; Brandt KR; Vachon CM; Grant CS; Degnim AC
    J Am Coll Surg; 2010 Mar; 210(3):314-8. PubMed ID: 20193894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratification of palpable and nonpalpable breast cancer by method of detection and age.
    Perdue PW; Galbo C; Ghosh BC
    Ann Surg Oncol; 1995 Nov; 2(6):512-5. PubMed ID: 8591081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year.
    Haakinson DJ; Stucky CC; Dueck AC; Gray RJ; Wasif N; Apsey HA; Pockaj B
    Am J Surg; 2010 Dec; 200(6):712-7; discussion 717-8. PubMed ID: 21146009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
    Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
    J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival experience in the Breast Cancer Detection Demonstration Project.
    Seidman H; Gelb SK; Silverberg E; LaVerda N; Lubera JA
    CA Cancer J Clin; 1987; 37(5):258-90. PubMed ID: 3115506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is surgical management compromised in elderly patients with breast cancer?
    Wanebo HJ; Cole B; Chung M; Vezeridis M; Schepps B; Fulton J; Bland K
    Ann Surg; 1997 May; 225(5):579-86; discussion 586-9. PubMed ID: 9193185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.